科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/12/24 | 6,070 | 6,080 | 6,000 | 6,040 | +10 | +0.2% | 49,600 |
| 2019/12/23 | 6,080 | 6,080 | 6,000 | 6,030 | -70 | -1.1% | 44,400 |
| 2019/12/20 | 6,160 | 6,160 | 6,050 | 6,100 | -50 | -0.8% | 80,000 |
| 2019/12/19 | 6,110 | 6,180 | 6,110 | 6,150 | +40 | +0.7% | 70,900 |
| 2019/12/18 | 6,100 | 6,110 | 6,050 | 6,110 | -10 | -0.2% | 97,900 |
| 2019/12/17 | 6,100 | 6,130 | 6,060 | 6,120 | +40 | +0.7% | 74,600 |
| 2019/12/16 | 6,040 | 6,150 | 6,030 | 6,080 | +50 | +0.8% | 100,800 |
| 2019/12/13 | 6,030 | 6,110 | 6,020 | 6,030 | +100 | +1.7% | 183,900 |
| 2019/12/12 | 5,960 | 5,980 | 5,910 | 5,930 | -40 | -0.7% | 72,900 |
| 2019/12/11 | 6,000 | 6,040 | 5,960 | 5,970 | -30 | -0.5% | 59,000 |
| 2019/12/10 | 6,010 | 6,020 | 5,960 | 6,000 | -10 | -0.2% | 87,700 |
| 2019/12/09 | 6,000 | 6,020 | 5,970 | 6,010 | +40 | +0.7% | 62,100 |
| 2019/12/06 | 5,940 | 5,990 | 5,930 | 5,970 | -10 | -0.2% | 56,100 |
| 2019/12/05 | 5,970 | 5,980 | 5,920 | 5,980 | +40 | +0.7% | 80,800 |
| 2019/12/04 | 5,890 | 5,970 | 5,880 | 5,940 | +30 | +0.5% | 75,700 |
| 2019/12/03 | 5,890 | 5,970 | 5,870 | 5,910 | -60 | -1% | 95,200 |
| 2019/12/02 | 5,930 | 5,980 | 5,910 | 5,970 | +80 | +1.4% | 78,800 |
| 2019/11/29 | 5,910 | 5,960 | 5,880 | 5,890 | +10 | +0.2% | 94,300 |
| 2019/11/28 | 5,890 | 5,900 | 5,830 | 5,880 | +20 | +0.3% | 72,300 |
| 2019/11/27 | 5,860 | 5,900 | 5,860 | 5,860 | +10 | +0.2% | 54,100 |
| 2019/11/26 | 5,900 | 5,900 | 5,820 | 5,850 | -10 | -0.2% | 153,100 |
| 2019/11/25 | 5,850 | 5,880 | 5,820 | 5,860 | +10 | +0.2% | 46,300 |
| 2019/11/22 | 5,890 | 5,900 | 5,840 | 5,850 | -10 | -0.2% | 79,500 |
| 2019/11/21 | 5,850 | 5,880 | 5,780 | 5,860 | -10 | -0.2% | 76,600 |
| 2019/11/20 | 5,870 | 5,880 | 5,810 | 5,870 | +50 | +0.9% | 95,300 |
| 2019/11/19 | 5,790 | 5,900 | 5,790 | 5,820 | -30 | -0.5% | 65,900 |
| 2019/11/18 | 5,850 | 5,870 | 5,820 | 5,850 | +20 | +0.3% | 68,300 |
| 2019/11/15 | 5,750 | 5,850 | 5,730 | 5,830 | +100 | +1.7% | 86,500 |
| 2019/11/14 | 5,750 | 5,820 | 5,720 | 5,730 | -40 | -0.7% | 69,300 |
| 2019/11/13 | 5,880 | 5,890 | 5,770 | 5,770 | -140 | -2.4% | 116,200 |
| 2019/11/12 | 5,880 | 5,930 | 5,870 | 5,910 | -20 | -0.3% | 72,600 |
| 2019/11/11 | 5,940 | 5,960 | 5,860 | 5,930 | +80 | +1.4% | 105,500 |
| 2019/11/08 | 5,820 | 5,910 | 5,800 | 5,850 | +130 | +2.3% | 159,700 |
| 2019/11/07 | 5,530 | 5,970 | 5,530 | 5,720 | +290 | +5.3% | 316,000 |
| 2019/11/06 | 5,480 | 5,510 | 5,390 | 5,430 | -40 | -0.7% | 127,500 |
| 2019/11/05 | 5,350 | 5,470 | 5,320 | 5,470 | +180 | +3.4% | 98,100 |
| 2019/11/01 | 5,310 | 5,310 | 5,270 | 5,290 | -30 | -0.6% | 58,200 |
| 2019/10/31 | 5,390 | 5,390 | 5,310 | 5,320 | -30 | -0.6% | 71,300 |
| 2019/10/30 | 5,360 | 5,410 | 5,330 | 5,350 | -10 | -0.2% | 106,100 |
| 2019/10/29 | 5,360 | 5,420 | 5,350 | 5,360 | +50 | +0.9% | 76,400 |
| 2019/10/28 | 5,350 | 5,350 | 5,300 | 5,310 | -20 | -0.4% | 73,100 |
| 2019/10/25 | 5,310 | 5,330 | 5,260 | 5,330 | +70 | +1.3% | 124,300 |
| 2019/10/24 | 5,280 | 5,280 | 5,230 | 5,260 | +50 | +1% | 65,200 |
| 2019/10/23 | 5,160 | 5,220 | 5,140 | 5,210 | +100 | +2% | 100,200 |
| 2019/10/21 | 5,140 | 5,160 | 5,100 | 5,110 | +20 | +0.4% | 58,900 |
| 2019/10/18 | 5,150 | 5,170 | 5,090 | 5,090 | -20 | -0.4% | 78,800 |
| 2019/10/17 | 5,110 | 5,140 | 5,090 | 5,110 | +10 | +0.2% | 84,300 |
| 2019/10/16 | 5,090 | 5,140 | 5,070 | 5,100 | +80 | +1.6% | 92,500 |
| 2019/10/15 | 4,990 | 5,060 | 4,990 | 5,020 | +110 | +2.2% | 79,300 |
| 2019/10/11 | 4,930 | 4,930 | 4,875 | 4,910 | -15 | -0.3% | 76,600 |
1301～
1350
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 414,000円 | +30.5% | +111.0% | 4.59% | 11.67倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 住友ファーマ | 61,900円 | +21.1% | - | 0.00% | 15.37倍 | 2.15倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ペプチド | 187,700円 | +5.0% | +1.5% | 0.00% | 16.11倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 383,500円 | +14.5% | -2.3% | 2.35% | 14.03倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 228,200円 | - | - | 0.00% | - | 105.70倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
